Mural Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Globe Newswire • about 1 month agoWALTHAM, Mass. and DUBLIN, Ireland, April 04, 2024 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company leveraging its core competencies in immune cell...